Solution Partner of Leading Manufacturers
Specific Laboratory Solutions Since 2012 , we have been offering sales, service and spare parts supply and application for R&D laboratories, routine diagnostic laboratories and IVF clinics and we realize turnkey laboratory projects.
As the Eastern Anatolia Regional Distributor of CARL ZEISS Turkey, our company offers microscope solutions for biomedical research, healthcare, and high-tech industries.
BioXp® 9600 system
Turkey Distributorship
Özgül Medikal contributes to the goal of optimizing many workflows such as antibody drug discovery, cell and gene therapy, vaccine development with Telesis Bio, a groundbreaking automation solution for biological synthesis, as the Main Distributor in Turkey.
End to End
Automation Solutions
Telesis Bio and the BioXp™ system automate, accelerate, and optimize DNA design and synthesis processes. From drug discovery, vaccine development, DNA data storage, and more, it offers innovators speed and security while securely protecting your designs.
Our gene synthesis portfolios reduce turnaround times in biological processes from weeks and months to just days and hours. In this context, the world’s first BioXp™ 3200 gene printer, variant library services, and Gibson Assembly® reagents offer fast and efficient solutions
We offer sales, service, spare parts supply & application; we realize turnkey laboratory projects
IVF Solutions
Our company, the Cooper Surgical brand’s regional distributor and the global market’s industry leader, creates result-oriented solutions with its medium and consumable group for Andrology and Embryology centers. We realize turnkey laboratory projects together with the other partners we cooperate with.
We work with industry leaders in the global market
Together with our solution partners that we represent in the region, we offer comprehensive analysis solutions in chemical, petrochemical, food, pharmaceutical and life science application areas
Strategic Research Collaboration
A strategic research collaboration was established with Telesis Bio to access their enzymatic DNA synthesis technology and to develop potential applications of this technology for Pfizer‘s mRNA-based vaccines and other biopharmaceutical products.
Codex DNA signed an early access collaboration and licensing agreement with Pfizer to further enhance Pfizer’s R&D efforts on mRNA-based vaccines and biotherapies using Codex DNA’s novel enzymatic DNA synthesis technology.
Solution Partners
Contact us
Contact us
Contact us for your questions and cooperation requests